The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors

Noch nicht übersetzt Noch nicht übersetzt
Kategorie Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The study consists of the two parts, the first one is SHR7390 combined with SHR-1210, the second one is SHR7390 combined with SHR-1210 and SHR3162. Two parts of the study are separately to assess the safety and tolerability, to define dose limiting toxicity(DLT) and maximum tolerated dose (MTD),to evaluate the pharmacokinetics ,to assess the antitumor activity in patients with advanced solid tumors preliminarily and to recommend reasonable dosage regimen of SHR7390 for the follow-up clinical trial.
Epistemonikos ID: 89f88a627c4f54f0221270e7532a4cfea12bf69f
First added on: May 20, 2024